Extended interval BNT162b2 vaccination enhances peak antibody generation

Abstract The BNT162b2 vaccine is highly effective against COVID-19 infection and was delivered with a 3-week time interval in registration studies1. However, many countries extended this interval to accelerate population coverage with a single vaccine. It is not known how immune responses are influe...

Full description

Bibliographic Details

Published in:	npj Vaccines
Main Authors:	Helen Parry, Rachel Bruton, Christine Stephens, Christopher Bentley, Kevin Brown, Gayatri Amirthalingam, Bassam Hallis, Ashley Otter, Jianmin Zuo, Paul Moss
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-01-01
Online Access:	https://doi.org/10.1038/s41541-022-00432-w